Clinical Trials Logo

Clinical Trial Summary

Only 24 cases of Campylobacter bone and joint infection (BJI) have been reported worldwide between 1955 and 2008. Between 2010 and 2012, 7 cases were observed in two University hospitals in France. This increasing number of cases raises several issues. Are they the consequences of better detections and reporting, or are they reflecting any epidemiologic changes? For answering these questions, we performed a 10 year (2002-2012) retrospective multicenter (6 centers) study on BJI (native and implanted joints) due to Campylobacter species.


Clinical Trial Description

Methods: By browsing the microbiological database of 6 BJI French reference centers, we collected all cases due to Campylobacter species between 2002 and 2012, including first and relapse cases. Clinical, microbiological and treatment features were analyzed using descriptive statistics.

Results: 14 episodes of BJI due to Campylobacter spp were identified in 10 patients. Mean age was 76.8 y.o. (63-96). Sex ratio M/F was 1.5. Nine patient had hip (n=6), knee (n=2), and shoulder (n=2) implants. Immunosuppression was observed in 6 patients (3 cancers, 1 cirrhosis, 1 rheumatoid arthritis, 1 corticosteroid treatment). During the 10 primary cases: all patients had fever and 2 presented digestive symptoms. Campylobacter spp were isolated on per operative samples in 5 patients. One of them presented positive blood culture. 5 patients had joint punctures: all of them were positives. Campylobacter species were C. fetus (n=7), C. coli (n=2) and C. spp (1). Strains were resistant to nalidixic acid (=10), ciprofloxacin (n=4), erythromycin (n=3) or cefotaxime (n=2). Only one C. fetus was susceptible to all antibiotics tested. Surgical treatment was performed in 8 patients (2 two-stage procedure, 6 irrigation). The mean duration of adapted antibiotherapy was 77 days (26-237). 3 out of 4 relapse cases were due to C. fetus. All were resistant to more than one antibiotic classes. ;


Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT02884752
Study type Observational
Source University Hospital, Brest
Contact
Status Completed
Phase N/A
Start date December 2014
Completion date July 2015

See also
  Status Clinical Trial Phase
Completed NCT03683667 - Protein Plus: Improving Infant Growth Through Diet and Enteric Health Phase 2/Phase 3
Completed NCT03266068 - Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
Not yet recruiting NCT06432777 - Recurrent Campylobacter Bacteraemia in Immunocompromised Patients
Active, not recruiting NCT02040922 - Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota N/A
Recruiting NCT01048112 - Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection Phase 1
Recruiting NCT06425250 - Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study
Completed NCT04182490 - LMN-101 in a Campylobacter Human Challenge Model Phase 2
Active, not recruiting NCT00434798 - Campylobacter Jejuni Challenge Model Development: Dose Ranging Study Phase 1